Skip to main content

Table 1 Characteristics of the participants in the first screening step (n = 3,120) by sex including Finnish Diabetes Risk Score (FINDRISC) findings

From: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy

Parameter

Overall

Male

Female

p

Number of participants, n

3120

1077 (34.5)

2043 (65.5)

-

Age, years

60.1 ± 8.3

61.3 ± 8.3

59.5 ± 8.2

<0.01

   45 to 54

941 (30.2)

275 (25.5)

666 (32.6)

 

   55 to 64

1157 (37.1)

377 (35.0)

780 (38.2)

 

   >65

1022 (32.8)

425 (39.5)

597 (29.2)

 

BMI, kg/m2

28.8 ± 4.6

28.7 ± 4.0

28.9 ± 4.9

0.38

   <25

612 (19.6)

185 (17.2)

427 (20.9)

 

   25 to 30

1464 (46.9)

555 (51.5)

909 (44.5)

 

   ≥30

1044 (33.5)

337 (31.3)

707 (34.6)

 

Waist circumference, cm

95.6 ± 11.5

100.0 ± 10.0

93.4 ± 11.6

<0.01

   M <94, F <80

517 (16.6)

256 (23.8)

261 (12.8)

 

   M 94 to 102, F 80 to 88

942 (30.2)

402 (37.7)

540 (26.4)

 

   M ≥103, F ≥89

1661 (53.2)

419 (38.9)

1242 (60.8)

 

Systolic blood pressure, mmHg

131.7 ± 15.4

134.0 ± 14.7

130.5 ± 15.7

<0.01

Diastolic blood pressure, mmHg

78.2 ± 10.6

79.0 ± 9.3

77.8 ± 11.1

<0.01

FINDRISC, points

11.8 ± 4.5

11.4 ± 4.4

12.0 ± 4.6

<0.01

   Low risk (<7)

346 (11.1)

136 (12.6)

210 (10.3)

 

   Slightly increased risk (7 to 11)

1221 (39.1)

441 (40.9)

780 (38.2)

 

   Moderate risk (12 to 14)

713 (22.9)

235 (21.8)

478 (23.4)

 

   High risk (15 to 20)

741 (23.8)

244 (22.7)

497 (24.3)

 

   Very high risk (>20)

99 (3.2)

21 (1.9)

78 (3.8)

 
  1. aData are means ± SE for quantitative variables or n (%) for qualitative variables.